• 1. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 2. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 3. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

• Pharmaceutical and Biochemical Products Medicinal Building Blocks Fluorine containing Building Blocks

Introduction to 4-Bromophenyl trifluoromethanesulfonate (CAS No. 129112-25-0)

4-Bromophenyl trifluoromethanesulfonate, identified by its Chemical Abstracts Service (CAS) number 129112-25-0, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound serves as a crucial intermediate in the synthesis of various biologically active molecules, particularly in the development of novel therapeutic agents. Its unique structural features, combining a brominated phenyl ring with a trifluoromethanesulfonate (triflates) group, make it a versatile building block for medicinal chemists.

The bromophenyl moiety in 4-Bromophenyl trifluoromethanesulfonate contributes to its reactivity, enabling various coupling reactions such as Suzuki-Miyaura and Buchwald-Hartwig couplings. These reactions are fundamental in constructing complex molecular architectures, which are often required for achieving high affinity and selectivity in drug design. The presence of the trifluoromethanesulfonate group further enhances its utility by providing a leaving group that can be displaced under mild conditions, facilitating the introduction of diverse functional groups into the molecule.

In recent years, there has been a surge in research focused on the development of small-molecule inhibitors targeting protein-protein interactions (PPIs). 4-Bromophenyl trifluoromethanesulfonate has emerged as a key intermediate in the synthesis of such inhibitors due to its ability to modulate binding affinities through steric and electronic effects. For instance, studies have demonstrated its role in generating potent inhibitors of kinases and other enzymes involved in cancer pathways. The triflate group allows for easy modification via nucleophilic substitution, enabling the fine-tuning of pharmacokinetic properties such as solubility and metabolic stability.

Moreover, the pharmaceutical industry has leveraged 4-Bromophenyl trifluoromethanesulfonate in the synthesis of antiviral and antibacterial agents. The bromine atom on the phenyl ring can be selectively modified to introduce additional functional groups, leading to compounds with enhanced biological activity. Recent advancements in flow chemistry have further optimized the synthesis of this compound, allowing for scalable production under controlled conditions. This has been particularly beneficial for academic and industrial laboratories aiming to explore novel drug candidates efficiently.

The agrochemical sector has also recognized the potential of 4-Bromophenyl trifluoromethanesulfonate as a precursor for developing next-generation pesticides. Its structural motifs are found in several commercially successful herbicides and fungicides, where the bromophenyl ring contributes to binding specificity against target enzymes in plants. By incorporating fluorine atoms via subsequent reactions, researchers can improve the environmental persistence and efficacy of these agrochemicals while minimizing off-target effects.

From a synthetic chemistry perspective, 4-Bromophenyl trifluoromethanesulfonate exemplifies the importance of heteroatom-containing functional groups in modern drug discovery. The triflate group is particularly valuable because it can be selectively removed or replaced under mild conditions, making it an ideal tool for constructing complex scaffolds. This flexibility has been exploited in numerous synthetic strategies, including transition-metal-catalyzed cross-coupling reactions and organocatalytic transformations.

The development of computational methods for predicting molecular properties has further accelerated the use of 4-Bromophenyl trifluoromethanesulfonate in drug design. Algorithms such as molecular docking and quantum mechanical calculations allow researchers to assess binding affinities and predict metabolic pathways before conducting experimental synthesis. This integration of computational chemistry with traditional organic synthesis has reduced time-to-market for new therapeutics significantly.

In conclusion, 4-Bromophenyl trifluoromethanesulfonate (CAS No. 129112-25-0) is a multifaceted compound with broad applications across pharmaceuticals, agrochemicals, and materials science. Its unique structural features make it an indispensable intermediate for synthesizing biologically active molecules, while its reactivity allows for diverse chemical modifications. As research continues to uncover new synthetic methodologies and biological targets, the importance of this compound is expected to grow further, solidifying its role as a cornerstone in modern chemical biology.

• 126613-08-9(Methanesulfonic acid, trifluoro-, 1-bromo-2-naphthalenyl ester)
• 3857-83-8(2-Naphthyl trifluoromethanesulfonate)
• 17763-67-6(Phenyl trifluoromethanesulfonate)
• 17763-91-6(Catechol bis(trifluoromethanesulfonate))
• 151600-02-1(6-Bromo-2-naphthyl Trifluoromethanesulfonate)
• 29540-83-8(p-Tolyl trifluoromethanesulfonate)
• 99747-74-7(1-NAPHTHYL TRIFLATE)
• 198624-12-3(4'-Bromobiphenyl-4-yl triflate)
• 66107-30-0(Methanesulfonic acid, trifluoro-, 4-bromophenyl ester)
• 138719-95-6(Methanesulfonic acid, trifluoro-, 2-bromo-4-methylphenyl ester)